Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

[Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology].

Beckert S, Struller F, Grischke EM, Glatzle J, Zieker D, Königsrainer A, Königsrainer I.

Zentralbl Chir. 2016 Aug;141(4):415-20. doi: 10.1055/s-0033-1350857. Epub 2013 Nov 15. German.

PMID:
24241953
2.

Preoperative Preparation and Patient Selection for Cytoreductive Surgery and HIPEC.

Ashvin R, Nikhilesh J.

Indian J Surg Oncol. 2016 Jun;7(2):208-14. doi: 10.1007/s13193-016-0514-4. Epub 2016 Feb 27. Review.

3.

[Cytoreductive surgery and HIPEC for peritoneal malignancies in children].

Seitz G, Fuchs J, Königsrainer I, Warmann SW, Königsrainer A, Beckert S.

Zentralbl Chir. 2014 Dec;139(6):607-12. doi: 10.1055/s-0034-1383240. Epub 2014 Dec 22. Review. German.

PMID:
25531634
4.

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

Spiliotis J, Halkia E, de Bree E.

Curr Oncol. 2016 Jun;23(3):e266-75. doi: 10.3747/co.23.2831. Epub 2016 Jun 9. Review.

5.

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.

Wong JF, Tan GH, Wang W, Soo KC, Teo MC.

World J Surg. 2015 Jun;39(6):1578-83. doi: 10.1007/s00268-015-2986-8.

PMID:
25651962
6.

Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.

Losa F, Barrios P, Salazar R, Torres-Melero J, Benavides M, Massuti T, Ramos I, Aranda E.

Clin Transl Oncol. 2014 Feb;16(2):128-40. doi: 10.1007/s12094-013-1053-x. Epub 2013 Jun 6. Review.

PMID:
23740133
7.

201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre.

Tan G, Chia C, Kumar M, Choo SP, Chia J, Tham CK, Chua C, Soo KC, Teo M.

Int J Hyperthermia. 2016 Dec 14:1-7. [Epub ahead of print]

PMID:
27855557
8.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
9.

Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.

Passot G, Bakrin N, Isaac S, Decullier E, Gilly FN, Glehen O, Cotte E.

Eur J Surg Oncol. 2014 Aug;40(8):957-62. doi: 10.1016/j.ejso.2013.10.002. Epub 2013 Oct 16.

PMID:
24209429
10.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
11.

Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kuijpers AM, Mehta AM, Aalbers AG, van Driel WJ, Boot H, Verwaal VJ.

Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28.

PMID:
24630923
12.
13.

Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.

Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.

PMID:
25145504
14.

Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.

Cioppa T, Vaira M, Bing C, D'Amico S, Bruscino A, De Simone M.

World J Gastroenterol. 2008 Nov 28;14(44):6817-23.

15.

Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?

Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G, Glehen O; BIG RENAPE Group.

Ann Surg Oncol. 2016 Jun;23(6):1971-9. doi: 10.1245/s10434-015-5081-3. Epub 2016 Jan 11.

PMID:
26753751
16.

Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Riss S, Mohamed F, Dayal S, Cecil T, Stift A, Bachleitner-Hofmann T, Moran B.

Eur J Surg Oncol. 2013 Sep;39(9):931-7. doi: 10.1016/j.ejso.2013.06.001. Epub 2013 Jun 27. Review.

PMID:
23810280
17.

Management of colorectal cancer patients at high risk of peritoneal metastases.

Shariff U, Seretis C, Youssef H.

J BUON. 2015 May;20 Suppl 1:S71-9.

PMID:
26051336
18.

Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases.

Königsrainer I, Horvath P, Struller F, Königsrainer A, Beckert S.

J Gastric Cancer. 2014 Jun;14(2):117-22. doi: 10.5230/jgc.2014.14.2.117. Epub 2014 Jun 30.

19.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
20.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834

Supplemental Content

Support Center